SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Welcome to the GENT board. GENT has the first drug for VOD.
An SI Board Since July 2006
Posts SubjectMarks Bans Symbol
408 17 0 GENT
Emcee:  rareearth42 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
133Italy's Gentium says shareholder sues co Tue Aug 26, 2008 5:35pm EDT Aug 26tnsaf-8/26/2008
132Probably not. Results should be out pretty soon? Whatever may happen, I hoperkrw-8/21/2008
131[Defibrotide moa explored] >>Blood. 2008 Aug 18. [Epub ahead of print] Atuck-8/21/2008
130[Severe veno-occlusive disease after autologous peripheral blood stem cell transtuck-8/21/2008
129[Hepatic veno-occlusive disease after tandem autologous stem cell transplantatiotuck-8/13/2008
128>>Gentium Reports First Quarter Financial Results; Provides Financial and tuck-6/26/2008
127The word <i>prospective</i> in this context means the evaluators choDewDiligence_on_SI-6/6/2008
126DD, When you run a double blinded study you are able to collect the same data, IRWIN JAMES FRANKEL-6/6/2008
125<i>This all strikes me as a rather unsatisfactory way of doing a "conDewDiligence_on_SI-6/6/2008
124It is probably a little of everything re: the historical arm. Some are lost to kenhott-6/6/2008
123I didn't notice Mike K. on the call. I wonder how many people were trying tkenhott-6/6/2008
122>>obviously there are limits as to how much they can screw up the process.IRWIN JAMES FRANKEL-6/6/2008
121I see Rodman & Renshaw downgraded this morning. I couldn't even tell iftuck-6/6/2008
120An AC would very likely be positive. They get some play because of the nature okenhott-6/6/2008
119Seems like it could get interesting if they file and get a panel review. FDA cherkrw-6/6/2008
118The major risks here is definitely the mgt. They pretty well are not very good.kenhott-6/6/2008
117<i>Overall, sell off does seem an over reaction to me. Others got post CC pgo-neil-6/5/2008
116Tuck, didn't listen to the call but noticed this update. Doubt it helps muchfred hayes-6/5/2008
115Raw notes from CC follow. Hope others listened, because there were a lot of thituck-6/5/2008
114Whatever the case is, they gave them a specific number to upsize to hit significrkrw-6/5/2008
113>> Probably a smaller than expected rate of vod in the control arm. But wIRWIN JAMES FRANKEL-6/5/2008
112Probably a smaller than expected rate of vod in the control arm.rkrw-6/5/2008
111Suppose the mkt is responding to the larger trial size. That may suggest a smalIRWIN JAMES FRANKEL-6/5/2008
110Press Release Source: Gentium S.p.A Gentium Announces Completion of Data SafetyIRWIN JAMES FRANKEL-6/5/2008
109>>Gentium Announces Completion of Data Safety Monitoring Board Review and tuck-6/5/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News